Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Human immunodeficiency virus.

Artykuły w czasopismach na temat „Human immunodeficiency virus”

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Human immunodeficiency virus”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Lederman, Michael. "Haemophilia, human immunodeficiency virus and human immunodeficiency virus pathogenesis." Thrombosis and Haemostasis 104, no. 11 (2010): 911–14. http://dx.doi.org/10.1160/th10-02-0096.

Pełny tekst źródła
Streszczenie:
SummaryIn July 1982, the occurrence of three cases of acquired immunodeficiency syndrome (AIDS) in men with haemophilia was an immediate signal to Oscar Ratnoff that AIDS was transmissible through blood products. Work that he led provided important and clear indication that the AIDS agent was transmissible through pooled plasma products and had rapidly infected many men who had haemophilia. Before the blood supply was protected, the risk for infection in haemophilia was related directly to the intensity of therapy with pooled anti-haemophilic factor concentrates. Studies performed among the sm
Style APA, Harvard, Vancouver, ISO itp.
2

Kamal, K. "Human Immunodeficiency Virus." Pediatrics in Review 26, no. 2 (2005): 67. http://dx.doi.org/10.1542/pir.26-2-67.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Price, TW, SG DeMars, DL Palmer, MI Altman, and JW Moore. "Human immunodeficiency virus." Journal of the American Podiatric Medical Association 80, no. 9 (1990): 510. http://dx.doi.org/10.7547/87507315-80-9-510.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Kamal, Khalid. "Human Immunodeficiency Virus." Pediatrics In Review 26, no. 2 (2005): 67. http://dx.doi.org/10.1542/pir.26.2.67.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Autran, Brigitte. "Human Immunodeficiency Virus." Expert Review of Vaccines 3, sup1 (2004): S3—S4. http://dx.doi.org/10.1586/14760584.3.4.s3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

DYKEMAN, MARGARET, KELLY FUGATE, and SARAH LAU. "Human Immunodeficiency Virus." Nurse Practitioner 22, no. 3 (1997): 94???104. http://dx.doi.org/10.1097/00006205-199703000-00008.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Brown, F. "Human immunodeficiency virus." Science 232, no. 4757 (1986): 1486. http://dx.doi.org/10.1126/science.3012776.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Skinner, Anita. "Human immunodeficiency virus." Nursing Standard 31, no. 13 (2016): 64–65. http://dx.doi.org/10.7748/ns.31.13.64.s46.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Phillips, David M. "Human Immunodeficiency Virus." New England Journal of Medicine 332, no. 4 (1995): 233. http://dx.doi.org/10.1056/nejm199501263320406.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Isaacs, David, and John Ziegler. "HUMAN IMMUNODEFICIENCY VIRUS." Pediatric Infectious Disease Journal 12, no. 12 (1993): 1038. http://dx.doi.org/10.1097/00006454-199312000-00024.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
11

RISI, GEORGE F., RICHARD H. GAUMER, STEVEN WEEKS, JEAN K. LEETE, and CHARLES V. SANDERS. "Human Immunodeficiency Virus." Southern Medical Journal 82, no. 9 (1989): 1079–82. http://dx.doi.org/10.1097/00007611-198909000-00005.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
12

Maschera, Barbara, Graham Darby, Giorgio Palú, et al. "Human Immunodeficiency Virus." Journal of Biological Chemistry 271, no. 52 (1996): 33231–35. http://dx.doi.org/10.1074/jbc.271.52.33231.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
13

Weissberg, Dov. "Human immunodeficiency virus." Annals of Thoracic Surgery 48, no. 5 (1989): 745. http://dx.doi.org/10.1016/0003-4975(89)90821-7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
14

Gaiser, Robert. "Human Immunodeficiency Virus." Survey of Anesthesiology 48, no. 6 (2004): 292–93. http://dx.doi.org/10.1097/01.sa.0000144233.48390.52.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
15

Siripurapu, Rekha, and Yoshiaki Ota. "Human Immunodeficiency Virus." Neuroimaging Clinics of North America 33, no. 1 (2023): 147–65. http://dx.doi.org/10.1016/j.nic.2022.07.014.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
16

Malani, Preeti N. "Human Immunodeficiency Virus." JAMA 316, no. 2 (2016): 238. http://dx.doi.org/10.1001/jama.2016.7995.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
17

Das, Pankaj, Neelam Singh, Veena Kharayat, et al. "Human Immunodeficiency Virus." Journal of the Dermatology Nurses' Association 17, no. 1 (2025): 14–18. https://doi.org/10.1097/jdn.0000000000000823.

Pełny tekst źródła
Streszczenie:
ABSTRACT Often overlooked or misdiagnosed, cutaneous symptoms are common in chronic human immunodeficiency virus (HIV) disease and can serve as early signs of the disease. These cutaneous signs prompted to test for HIV on the three patients, which all were found to be positive. In this article, we are attempting to highlight the importance of recognizing cutaneous manifestations of HIV for early diagnosis and timely initiation of antiretroviral therapy. Three cases of cutaneous symptoms are presented: (a) generalized hyperpigmentation; (b) generalized hyperpigmentation with oral hairy leukopla
Style APA, Harvard, Vancouver, ISO itp.
18

Tagawa, Miho. "4. Human Immunodeficiency Virus Associated Renal Dysfunction." Nihon Naika Gakkai Zasshi 100, no. 5 (2011): 1319–23. http://dx.doi.org/10.2169/naika.100.1319.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
19

M P Bhuvaneswari, Noufa. "Human Immunodeficiency Virus in Periodontal Treatment - A Review Article." International Journal of Science and Research (IJSR) 13, no. 3 (2024): 1731–34. http://dx.doi.org/10.21275/mr24326132154.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
20

Straub, OC, and D. Lévy. "Bovine immunodeficiency virus and analogies with human immunodeficiency virus." Leukemia 13, S1 (1999): S106—S109. http://dx.doi.org/10.1038/sj.leu.2401324.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
21

Adhikari, Nilaramba, Ratna Bhattarai, Rajendra Basnet, Bhim Singh Tinkari, Badri Nath Gyawali, and Lok Raj Joshi. "Prevalence of Human Immunodeficiency Virus Infection among Tuberculosis Patients in Nepal." Journal of Nepal Health Research Council 17, no. 01 (2019): 15–20. http://dx.doi.org/10.33314/jnhrc.v17i01.1768.

Pełny tekst źródła
Streszczenie:
Background: National Tuberculosis Program has envisioned to provide human immunodeficiency virus testing for all tuberculosis patients. However, human immunodeficiency virus testing coverage among notified tuberculosis patients is very low in Nepal. Hence, it is difficult to reflect the prevalence of human immunodeficiency virus infection among Tuberculosis patients based on the information available from the routine system. Hence National Tuberculosis Program carried out sentinel surveillance to assess the prevalence of human immunodeficiency virus infection among tuberculosis patients and it
Style APA, Harvard, Vancouver, ISO itp.
22

Warner, Mark A., and Steve E. Kunkel. "Human Immunodeficiency Virus Infection." Anesthesiology Clinics of North America 7, no. 4 (1989): 795–811. http://dx.doi.org/10.1016/s0889-8537(21)00172-3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
23

Sinha, Nitin, Sahil Sareen, AshwiniKumar Malhotra, and Sanchit Singh. "Human immunodeficiency virus encephalitis." Indian Journal of Sexually Transmitted Diseases and AIDS 41, no. 1 (2020): 108. http://dx.doi.org/10.4103/ijstd.ijstd_112_16.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
24

Lakshmanan, Priyanka, and Ira Shah. "Human immunodeficiency virus polyarthropathy." Journal of Family Medicine and Primary Care 5, no. 3 (2016): 725. http://dx.doi.org/10.4103/2249-4863.197289.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
25

Wheat, Santina, and Evan Wittke. "Human Immunodeficiency Virus Care." Primary Care: Clinics in Office Practice 48, no. 2 (2021): 311–28. http://dx.doi.org/10.1016/j.pop.2021.02.011.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
26

CASE, KATHLEEN. "Nomenclature: Human Immunodeficiency Virus." Annals of Internal Medicine 105, no. 1 (1986): 133. http://dx.doi.org/10.7326/0003-4819-105-1-133.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
27

Hollander, Harry. "Human immunodeficiency virus infection." Postgraduate Medicine 81, no. 4 (1987): 79–84. http://dx.doi.org/10.1080/00325481.1987.11699742.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
28

Sinha, Uma, Prasanta Mukhopadhyay, Nilanjan Sengupta, and KeshabSinha Roy. "Human immunodeficiency virus endocrinopathy." Indian Journal of Endocrinology and Metabolism 15, no. 4 (2011): 251. http://dx.doi.org/10.4103/2230-8210.85574.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
29

Volberding, Paul A., Kelty R. Baker, and Alexandra M. Levine. "Human Immunodeficiency Virus Hematology." Hematology 2003, no. 1 (2003): 294–313. http://dx.doi.org/10.1182/asheducation-2003.1.294.

Pełny tekst źródła
Streszczenie:
Abstract The advent of potent antiretroviral therapy has altered the expected natural history of human immunodeficiency virus (HIV) infection and of many previously associated opportunistic complications, including malignancies. At the same time, HIV suppression hasn’t affected all of these complications equally and the longer expected survival of infected patients may allow the development of newer complications. Additionally, the use of potent antiretroviral combination therapy may itself lead to hematological toxicities. Together these changes affect the consultation role of the hematology-
Style APA, Harvard, Vancouver, ISO itp.
30

Palomino U, Brayan Alejandro. "HUMAN IMMUNODEFICIENCY VIRUS HIV." SCT Proceedings in Interdisciplinary Insights and Innovations 1 (December 5, 2023): 75. http://dx.doi.org/10.56294/piii202375.

Pełny tekst źródła
Streszczenie:
The HIV research project focused on deepening the understanding of the human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS), as well as developing effective strategies for their prevention, diagnosis and treatment. Key aspects such as the epidemiology of HIV/AIDS, risk factors, prevention strategies and access to antiretroviral treatment were investigated. Literature review activities, analysis of epidemiological data, field studies and evaluation of public health interventions were carried out. Collaboration with research institutions, public health organizations a
Style APA, Harvard, Vancouver, ISO itp.
31

Garland, Suzanne. "Human Immunodeficiency Virus (HIV)." Papillomavirus Report 15, no. 4 (2004): 229–32. http://dx.doi.org/10.1179/095741904225005133.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
32

Jones, Kimmith M. "Human Immunodeficiency Virus Disease." Critical Care Nursing Clinics of North America 11, no. 4 (1999): 455–64. http://dx.doi.org/10.1016/s0899-5885(18)30137-0.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
33

Tramont, COL Edmund C. "The Human Immunodeficiency Virus." Dermatologic Clinics 9, no. 3 (1991): 397–401. http://dx.doi.org/10.1016/s0733-8635(18)30390-5.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
34

Knobler, Robert M. "Human Immunodeficiency Virus Infection." Dermatologic Clinics 7, no. 2 (1989): 369–86. http://dx.doi.org/10.1016/s0733-8635(18)30606-5.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
35

Darke, P. L., C. T. Leu, L. J. Davis, et al. "Human immunodeficiency virus protease." Journal of Biological Chemistry 264, no. 4 (1989): 2307–12. http://dx.doi.org/10.1016/s0021-9258(18)94177-3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
36

SMITH, MIKE U., ROZ E. GOUDEAU, HAROLD P. KATNER, and J. THEODORE FARMER. "Human Immunodeficiency Virus Infection." Southern Medical Journal 86, no. 5 (1993): 537–44. http://dx.doi.org/10.1097/00007611-199305000-00010.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
37

Senturia, Y. D., and C. S. Peckham. "Neonatal human immunodeficiency virus." Current Opinion in Infectious Diseases 1, no. 3 (1988): 473–78. http://dx.doi.org/10.1097/00001432-198805000-00020.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
38

Hardy, William D. "THE HUMAN IMMUNODEFICIENCY VIRUS." Medical Clinics of North America 80, no. 6 (1996): 1239–61. http://dx.doi.org/10.1016/s0025-7125(05)70489-2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
39

Zurlo, John J. "The Human Immunodeficiency Virus." Otolaryngologic Clinics of North America 25, no. 6 (1992): 1159–81. http://dx.doi.org/10.1016/s0030-6665(20)30888-4.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
40

Chermann, J. C. "Human Immunodeficiency Virus (HIV)." Transfusion Science 11 (January 1990): S3—S7. http://dx.doi.org/10.1016/0955-3886(90)90076-u.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
41

Davis, Teaniese Latham, and Ralph DiClemente. "Human Immunodeficiency Virus Prevention." Child and Adolescent Psychiatric Clinics of North America 25, no. 2 (2016): 283–95. http://dx.doi.org/10.1016/j.chc.2015.11.006.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
42

TAIWO, BABAFEMI O., and CHARLES B. HICKS. "Primary Human Immunodeficiency Virus." Southern Medical Journal 95, no. 11 (2002): 1312–17. http://dx.doi.org/10.1097/00007611-200211000-00015.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
43

TAIWO, BABAFEMI O., and CHARLES B. HICKS. "Primary Human Immunodeficiency Virus." Southern Medical Journal 95, no. 11 (2002): 1312–17. http://dx.doi.org/10.1097/00007611-200295110-00016.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
44

Gallant, Joel E. "Human Immunodeficiency Virus Medicine." Journal of Infectious Diseases 216, suppl_5 (2017): S624—S625. http://dx.doi.org/10.1093/infdis/jix238.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
45

Goepfert, Paul, and Anju Bansal. "Human Immunodeficiency Virus Vaccines." Infectious Disease Clinics of North America 28, no. 4 (2014): 615–31. http://dx.doi.org/10.1016/j.idc.2014.08.004.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
46

Phair, J. P. "Human immunodeficiency virus antigenemia." JAMA: The Journal of the American Medical Association 258, no. 9 (1987): 1218. http://dx.doi.org/10.1001/jama.258.9.1218.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
47

Phair, John P. "Human Immunodeficiency Virus Antigenemia." JAMA: The Journal of the American Medical Association 258, no. 9 (1987): 1218. http://dx.doi.org/10.1001/jama.1987.03400090102044.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
48

Hulsebosch, Hendrik J., Frans A. P. Claessen, Cornelis J. W. van Ginkel, Guus R. R. Kuiters, Jaap Goudsmit, and Joep M. A. Lange. "Human immunodeficiency virus exanthem." Journal of the American Academy of Dermatology 23, no. 3 (1990): 483–86. http://dx.doi.org/10.1016/0190-9622(90)70245-d.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
49

Strauss, Jose, Gaston Zilleruelo, Carolyn Abitbol, Brenda Montane, and Victoriano Pardo. "Human immunodeficiency virus nephropathy." Pediatric Nephrology 7, no. 2 (1993): 220–25. http://dx.doi.org/10.1007/bf00864411.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
50

Cruz, Maria Leticia S. "Perinatally infected adolescents living with human immunodeficiency virus (perinatally human immunodeficiency virus)." World Journal of Virology 4, no. 3 (2015): 277. http://dx.doi.org/10.5501/wjv.v4.i3.277.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!